Clinical Trials Browser

INDUSTRY × DT2216 × Clear all

NCT04886622 2025-04-16

A Study of DT2216 in Relapsed/Refractory Malignancies

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms